414 related articles for article (PubMed ID: 19626642)
21. Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT.
Strobel K; Haerle SK; Stoeckli SJ; Schrank M; Soyka JD; Veit-Haibach P; Hany TF
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):919-27. PubMed ID: 19205699
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
Kim M; Higuchi T; Arisaka Y; Achmad A; Tokue A; Tominaga H; Miyashita G; Miyazaki H; Negishi A; Yokoo S; Tsushima Y
Ann Nucl Med; 2013 Jun; 27(5):423-30. PubMed ID: 23436243
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy response in head and neck cancer - evaluation of the primary tumour site.
Sjövall J; Brun E; Almquist H; Kjellén E; Wahlberg P
Acta Otolaryngol; 2014 Jun; 134(6):646-51. PubMed ID: 24707930
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic performance of response assessment FDG-PET/CT in patients with head and neck squamous cell carcinoma treated with high-precision definitive (chemo)radiation.
Gupta T; Jain S; Agarwal JP; Rangarajan V; Purandare N; Ghosh-Laskar S; Dinshaw KA
Radiother Oncol; 2010 Nov; 97(2):194-9. PubMed ID: 20627432
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of esophageal cancer during the pretreatment of hypopharyngeal cancer patients: routinely performed esophagogastroduodenoscopy and FDG-PET/CT findings.
Nakaminato S; Toriihara A; Makino T; Kawano T; Kishimoto S; Shibuya H
Acta Oncol; 2012 May; 51(5):645-52. PubMed ID: 22229748
[TBL] [Abstract][Full Text] [Related]
26. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Mani N; George MM; Nash L; Anwar B; Homer JJ
Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
[TBL] [Abstract][Full Text] [Related]
27. [
Linz C; Brands RC; Hackenberg S; Hartmann S; Iring T; Hohm J; Haug L; Kertels O; Kircher M; Dierks A; Buck AK; Brumberg J; Lapa C
J Craniomaxillofac Surg; 2022 Aug; 50(8):671-676. PubMed ID: 35794029
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of positron emission tomography/computed tomography in the management of advanced head and neck cancer.
Kurien G; Hu J; Harris J; Seikaly H
J Otolaryngol Head Neck Surg; 2011 Dec; 40(6):468-72. PubMed ID: 22420434
[TBL] [Abstract][Full Text] [Related]
29. 18F-FAMT-PET is useful for the diagnosis of lymph node metastasis in operable esophageal squamous cell carcinoma.
Sohda M; Kato H; Suzuki S; Tanaka N; Sano A; Sakai M; Inose T; Nakajima M; Miyazaki T; Fukuchi M; Oriuchi N; Endo K; Kuwano H
Ann Surg Oncol; 2010 Dec; 17(12):3181-6. PubMed ID: 20614194
[TBL] [Abstract][Full Text] [Related]
30. FDG PET/CT incidental diagnosis of a synchronous bladder cancer as a fourth malignancy in a patient with head and neck cancer.
Osman MM; Altinyay ME; Abdelmalik AG; Brickman TM; Varvares MA; Nguyen NC
Clin Nucl Med; 2011 Jun; 36(6):496-7. PubMed ID: 21552038
[TBL] [Abstract][Full Text] [Related]
31. Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors.
Bischoff M; Bischoff G; Buck A; von Baer A; Pauls S; Scheffold F; Schultheiss M; Gebhard F; Reske SN
Arch Orthop Trauma Surg; 2010 Jul; 130(7):819-27. PubMed ID: 19636577
[TBL] [Abstract][Full Text] [Related]
32. Metabolic tumour volume. Prognostic value in locally advanced squamous cell carcinoma of the head and neck.
Deron P; Mertens K; Goethals I; Rottey S; Duprez F; De Neve W; Vermeersch H; Van de Wiele C
Nuklearmedizin; 2011; 50(4):141-6. PubMed ID: 21594304
[TBL] [Abstract][Full Text] [Related]
33. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
[TBL] [Abstract][Full Text] [Related]
34. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
35. Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancer.
Vergez S; Delord JP; Thomas F; Rochaix P; Caselles O; Filleron T; Brillouet S; Canal P; Courbon F; Allal BC
Clin Cancer Res; 2010 Sep; 16(17):4434-45. PubMed ID: 20660574
[TBL] [Abstract][Full Text] [Related]
36. Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI.
Meerwein CM; Queiroz M; Kollias S; Hüllner M; Veit-Haibach P; Huber GF
Swiss Med Wkly; 2015; 145():w14116. PubMed ID: 25701645
[TBL] [Abstract][Full Text] [Related]
37. Three synchronous primary tumors with different histology detected by ¹⁸F-FDG PET/CT.
Eren MS; Ozdogan O; Koyuncuoglu M; Degirmenci B
Hell J Nucl Med; 2012; 15(1):56-8. PubMed ID: 22413115
[TBL] [Abstract][Full Text] [Related]
38. Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
Slevin F; Subesinghe M; Ramasamy S; Sen M; Scarsbrook AF; Prestwich RJ
Br J Radiol; 2015 Aug; 88(1052):20140592. PubMed ID: 26081447
[TBL] [Abstract][Full Text] [Related]
39. Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
Lee HS; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
Eur J Radiol; 2014 Aug; 83(8):1455-60. PubMed ID: 24929443
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.
Hannah A; Scott AM; Tochon-Danguy H; Chan JG; Akhurst T; Berlangieri S; Price D; Smith GJ; Schelleman T; McKay WJ; Sizeland A
Ann Surg; 2002 Aug; 236(2):208-17. PubMed ID: 12170026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
